Stratec SEStratec SEStratec SE

Stratec SE

No trades
See on Supercharts
Market capitalization
‪542.27 M‬USD
‪14.13 M‬USD
‪283.16 M‬USD
Beta (1Y)
1.35

About STRATEC SE

CEO
Marcus Wolfinger
Headquarters
Birkenfeld
Employees (FY)
‪1.52 K‬
Founded
1978
FIGI
BBG00TN52VM4
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.